Grifols (GIKLY) EBIT (QoQ) (2010 - 2020)
Grifols (GIKLY) EBIT (QoQ) (2010 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn |
| 10 | Grifols | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -65.50% |
| Mar 31, 2019 | -64.12% |
| Jun 30, 2018 | 3.93% |
| Mar 31, 2018 | -89.65% |
| Jun 30, 2017 | 16.45% |
| Mar 31, 2017 | 120.99% |
| Dec 31, 2016 | -579.87% |
| Sep 30, 2016 | 6.94% |
| Jun 30, 2016 | -2.11% |
| Mar 31, 2016 | -67.55% |
| Dec 31, 2015 | 186.09% |
| Sep 30, 2015 | 6.23% |
| Jun 30, 2015 | -3.04% |
| Sep 30, 2013 | -2.15% |
| Jun 30, 2013 | 1.83% |
| Mar 31, 2013 | -87.18% |
| Dec 31, 2012 | 799.81% |
| Sep 30, 2012 | -0.50% |
| Jun 30, 2012 | -3.87% |
| Mar 31, 2012 | -52.30% |